A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease - Concepedia

Concepedia

Publication | Open Access

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

DOI Full Paper Access

3.1K

Citations

27

References

1997

Year

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, T Schaible, Paul Rutgeerts

New England Journal of Medicine

Abstract

A single infusion of cA2 was an effective short-term treatment in many patients with moderate-to-severe, treatment-resistant Crohn's disease.

References

	Year	Citations

Page 1